Patients with CKD who discontinued ACE inhibitors or angiotensin receptor blockers after a hyperkalemia episode had a 2.6-fold increased risk of all-cause mortality compared with patients who continued taking the drugs.
Adult patients who used angiotensin receptor blockers prior to surgery had significant 30% increased odds of acute kidney injury, an Icelandic study found.
Users of selective serotonin reuptake inhibitors had a higher risk of hyponatremia than users of serotonin-norepinephrine reuptake inhibitors, especially with concurrent thiazide diuretic treatment.
Discontinuing angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy more than doubles the risk of death and dialysis initiation, according to a new study.
